In a guest blog post on the Center for Global Health Policy’s “Science Speaks,” Chris Collins, vice president and director of public policy at amfAR: The Foundation for AIDS Research, and Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention, summarize a Capitol Hill briefing “on the research agenda for beginning to end the AIDS epidemic” that took place Wednesday. “[R]esearchers, policymakers, and advocates joined our organizations and the Congressional HIV/AIDS Caucus” at the briefing to discuss “the research agenda needed to bring the epidemic to a close, with special focus on” combination interventions for treatment and prevention; “progress on vaccine and cure research”; and the importance of HIV testing, they write. Collins and Warren conclude, “We need to finance the response, make strategic choices about what to bring to scale (and what not to) and stop discriminating against high-risk populations. Whether you’re a researcher, policymaker or advocate, new scientific developments are how we end the epidemic” (5/24).
Global Health Conferences and Meetings
The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., “ignited momentum to shift from ‘fighting AIDS’ to ‘ending AIDS,'” Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece. “Oxfam believes investing in health systems such as infrastructure and health worker, drug supply chain and health information systems, is a critical prerequisite to ending AIDS,” they write. However, “to make this a reality,” pharmaceutical companies, donor governments, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank “must now do their part,” they continue.
In this post in Huffington Post’s “Impact” blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines “the success of U.S. efforts to promote better global health through support for [PEPFAR] and the Global Fund to Fight AIDS, Tuberculosis and Malaria.” She highlights U.S. Secretary of State Hillary Clinton’s recent trip to Africa, writing that Clinton’s “encouraging words” at the Reach Out Mbuya health center in Uganda reinforced U.S. commitment to an AIDS-free generation. She notes both PEPFAR and the Global Fund have supported the center and adds that “through hundreds of similar local programs all over the world, the Global Fund provides treatment to 3.6 million people who are HIV-positive.”
In this post in BMJ’s “Yankee Doodling,” Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation “if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment.” He writes that while there has been “astonishing progress against AIDS,” “two concerns immediately arise: the magnitude of the work remaining to find and continuously treat all those infected, and the confusion between that treatment (even if it is somehow universally successful) and actual eradication of the disease.” He concludes, “It is a rosy scenario, but even if it came true it still would not spell the end of the HIV story,” because “[w]e have no vaccine, and the virus keeps mutating” (8/14).
The Center for Global Health Policy’s “Science Speaks” blog examines how the “U.S. travel bans on people involved in sex work and people who have used illegal drugs … kept many of the people at highest risk from coming to the [XIX International AIDS Conference (AIDS 2012)]” in Washington, D.C., last month. “The result, observers said afterward, was a larger conference with fewer sex workers than had brought their first-hand experiences and concerns to Vienna and Mexico City,” according to the blog. Carlos Laudari, senior technical adviser for HIV AIDS prevention at Pathfinder, “and others said those in absentia were not the only ones disempowered; the loss of sex worker and drug user input on how to realize the goals of treatment as prevention, on barriers to funding, testing, health care access, and for that matter, on the difference between sex work and sex trafficking — commonly, and erroneously equated — weakened the dialogue and the action they were intended to inform,” the blog writes and quotes several other advocates (Barton, 8/8).
In this post in Huffington Post’s “Healthy Living” blog, John-Manuel Andriote, a journalist and author living with HIV, writes, “For all of us living with HIV infection — Oct. 27 will mark seven years since my own diagnosis — the question we face daily, hopefully more consciously and deliberately than most, is how shall we live, knowing as we do that we will most assuredly die one day?” Reflecting on the XIX International AIDS Conference (AIDS 2012) that took place in Washington last month, he continues, “An AIDS-free generation is certainly a worthy goal,” but “even if tens of billions of additional dollars are allocated to address HIV/AIDS, even if the Republicans don’t succeed in inflicting their Darwinian ‘survival of the fittest’ upon the nation and the world, the question will continue to be what it has been for 31 years … Will we have the political will to end AIDS?”
International AIDS Conference To Highlight International, Domestic U.S. AIDS Policies, Politico Reports
When the International AIDS Conference convenes in Washington in July, the first time the U.S. will host the conference in more than 20 years, “it will signal that the U.S. has brought its HIV policies into better alignment with the principles it advocates abroad,” Politico reports, referencing the lifting of the “Helms rule” — which denied U.S. visas to people who are HIV positive — in 2009. “The policy was especially painful to advocates because U.S. scientific and financial investments are largely responsible for stemming the tide of the epidemic around the world,” the news service writes. “But the meeting will also highlight other ways that the U.S. has fallen short, advocates say,” the news service writes, noting that the U.S. epidemic is not slowing. Politico discusses the successes and criticisms of several domestic HIV/AIDS initiatives under the Obama administration (Feder, 5/13).
AVAC and amfAR, the Foundation for AIDS Research, on Tuesday released the first (.pdf) in a series of quarterly reports following up on the release of the Action Agenda to End AIDS (.pdf), which was launched in July at the XIX International AIDS Conference (AIDS 2012), according to a joint press release. “New infections and AIDS deaths continue to decline, but not at a pace sufficient to meet the global goals of halving new infections among adults and eliminating new infections in children by 2015,” the report states and looks at data in the areas of strategy, investment, accountability, research, and efficiency (11/20).
NAM Publications, through aidsmap.org, will be an official news partner of the XIX International AIDS Conference (AIDS 2012), according to a post in the aidsmap blog. “Senior editor Keith Alcorn says, ‘This year’s conference will be the biggest yet, and after several years of exciting scientific developments, AIDS 2012 will challenge us all to ask how we can turn the tide of the epidemic using all the new tools and knowledge now at our disposal,'” the blog notes (Hughson, 7/10).
The Center for Strategic & International Studies (CSIS) on Tuesday released a report (.pdf) reflecting on lessons learned at the XIX International AIDS Conference (AIDS 2012), which took place in Washington, D.C., in July, J. Stephen Morrison, senior vice president and director of the Global Health Policy Center at CSIS reports in the center’s “Smart Global Health” blog. Morrison notes, “In the year leading up to the conference, CSIS played the unusual role of assembling a diverse high-level advisory group to assist the lead organizers in navigating the special challenges in the Washington political environment.” The report, titled “Lessons Learned from AIDS 2012,” examines “what AIDS 2012 achieved, why the CSIS advisory group was formed, what accounts for its impacts, and what that experience may foretell for future International AIDS Conferences,” Morrison writes in the blog (11/27).